Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Andreas Engert, Prof. MD
Woman and Man Max 99 years
Andreas Engert, Prof. MD
Update Il y a 4 ans
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
The purpose of this study is to determine the Maximum Tolerated Dose, Dose Limiting Toxicities and optimal dosing schedule of 4SC-202 investigating its safety, tolerability and pharmacokin...
Country
Germany
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Andreas Engert, Prof. MD
Update Il y a 4 ans
EMMA-1 (Erbitux for Multiple Myeloma)
EMMA-1 is an open-label, non-randomized, two-stage phase II study. Patients with refractory multiple myeloma stage II or III or relapsed disease after at least one line of treatment will r...
Country
None
organs
None
Specialty
None
Closed trial
More information